about
Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesionsSerum anti-BPAG1 auto-antibody is a novel marker for human melanomaHigh levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients.Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.Peripheral markers of brain damage and blood-brain barrier dysfunctionDiagnostic and prognostic biomarkers in melanoma.Biomarkers in melanoma: staging, prognosis and detection of early metastases.Surgical treatment of melanoma.Primary malignant melanoma of the stomach: report of a case.Prognostic signs in melanoma: state of the art.Immunohistochemistry in melanocytic proliferative lesions.The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression AnalysisMelanoma biomarkers: Vox clamantis in deserto (Review)Cutaneous melanoma: baseline and ongoing laboratory evaluation.S-100B concentrations predict disease-free survival in stage III melanoma patients.Protein and non-protein biomarkers in melanoma: a critical update.S100B as a marker for brain damage and blood-brain barrier disruption following exercise.Serum calcium, albumin and tumor stage in cutaneous malignant melanomaMetastatic pathways in patients with cutaneous melanoma.Exploratory investigation of eight circulating plasma markers in brain tumor patients.Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma.High plasma proteasome levels are detected in patients with metastatic malignant melanoma.High serum galectin-3 in advanced melanoma: preliminary results.Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patients.Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma.Circulating melanoma cells as a potential biomarker to detect metastasis and evaluate prognosis.Clinical use of p-proteasome in discriminating metastatic melanoma patients: Comparative study with LDH, MIA and S100B protein
P2860
Q30432850-9A5D7529-341D-4F62-8D32-AB9E0CACDB84Q30982790-8E8564EB-47D4-4868-BEA3-72F6852961DCQ33432819-99EEB3DC-5324-47D1-8D16-CF2EF4BF92FCQ33686729-7456992D-CA79-444D-99EF-AAFF977380F0Q33789473-4AD6C62A-5F8C-4D17-A7F8-B59D741153E6Q33862470-4E1CDFDD-1D62-4E03-8B27-DDEF5DE57841Q35142165-CFEA7A27-2F38-4A9F-ADDB-0BC95E57D9A3Q35188550-2AFD8A70-6E81-4721-8BF1-3ED0DB3C7787Q35691064-BBBC609F-DB2F-4328-A3E9-D029FF2D1608Q35750724-10892000-F77B-4458-B69C-836EBF8679A8Q35798186-AC4FADB4-1518-4229-957C-3BE6760DF1C8Q35947544-C0D52287-0487-444B-B389-48F8CD0DBA85Q36216949-CCC6B740-0E34-428F-B23B-E5D87E03075AQ36317101-7324CBF6-9AC4-4F4E-A51C-832E127EB21FQ37425922-49DC87F2-F184-48E7-97EC-EA8C6FF237D3Q38050990-343266B5-E94E-47A1-AEB8-7F4B8B1373A1Q38160208-F32910A7-D684-4C8A-904B-D952B4ECDE8CQ38852740-41DB7F38-4EF6-4B95-A7A6-89941DD84793Q39024316-7AC3AC68-9426-4C8D-9D12-E900BD30461CQ39319659-1B51E244-BFAC-4817-81CF-89AEED10DDADQ40027342-883BD446-7180-4E9E-AA2F-849E48897548Q43861059-034FBE7B-51FF-4676-A999-0CC32834D834Q46485667-CFBD738A-89A5-4DB1-A8DB-5F1A2FF73A0BQ46821420-54550F3E-361C-4124-BC12-50BFF0C45DFBQ48308467-4628AD5C-4A38-4F96-835E-EA79801C018CQ48331721-51D97094-AE11-4BA2-8F43-7BD7B2BFE97CQ50500281-58A75506-F909-4351-B4C8-7E4FF65D584CQ53160009-1CBCF813-D361-4D09-A0CF-33DE2D33103AQ58100438-8CF3C7AE-7866-4918-B9F4-AC3F3BD9CB9B
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Serological markers for melanoma.
@ast
Serological markers for melanoma.
@en
Serological markers for melanoma.
@nl
type
label
Serological markers for melanoma.
@ast
Serological markers for melanoma.
@en
Serological markers for melanoma.
@nl
prefLabel
Serological markers for melanoma.
@ast
Serological markers for melanoma.
@en
Serological markers for melanoma.
@nl
P2860
P1476
Serological markers for melanoma.
@en
P2093
Naeyaert JM
P2860
P304
P356
10.1046/J.1365-2133.2000.03649.X
P407
P577
2000-08-01T00:00:00Z